Skip to main content

Profhilo

High-concentration hyaluronic acid improves skin hydration and elasticity. Corrects fine lines and skin quality.

Treatment Information

Duration

20-30 minutes

Body Location

Face, neck, décolletage, hands or selected skin areas after assessment

Preparation

No special preparation is usually needed. Avoid alcohol for 24 hours; do not stop prescribed medication or blood thinners on your own, and disclose them to the physician.

Follow-up Care

Mild swelling may persist 24-48 hours. Use SPF 50+ sunscreen.

How It Is Performed

High-concentration hyaluronic acid injected into mid-dermis. Helps restore skin structure.

HA Filler vs Collagen Stimulator: A Strategic Choice in Facial Rejuvenation

Hyaluronic-acid (HA) fillers may be used for volume or structural support in selected areas. Biostimulators such as PLLA and CaHA differ in onset, intended use, and risk profile; products are not interchangeable. This matrix explains general decision factors and is not an individual treatment recommendation.

HA Filler vs Collagen Stimulator: A Strategic Choice in Facial Rejuvenation
CriterionHyaluronic Acid FillerCollagen Stimulator (PLLA / CaHA)
Mode of ActionAdds volume directly; visible immediately after injectionTriggers neocollagenesis; result builds gradually over 8–12 weeks
Onset of ResultsImmediate — same sessionDelayed — gradual over 2–3 months
Longevity9–18 months depending on product and areaVaries by product, area, protocol, and individual response; a fixed duration cannot be promised in advance.
Reversible?Some HA fillers may be reduced with hyaluronidase; complete or immediate reversal should not be assumed.No — must be metabolised naturally
Ideal AreaLips, cheeks, nasolabial, tear trough, jawline, handsBroad mid-face volume loss, temples, jowls, décolleté
Effect on Tissue QualityHydration, volume, or structural support may be targeted depending on product and treatment plan.Marked — improves skin thickness, firmness, and elasticity
Initial ProtocolIndividualised according to product, area, amount needed, and tissue response.Planned by the physician according to product information, area, and individual response.
Risk / Side Effect ProfileMild swelling/bruising; vascular events rare but seriousNodules, inflammation, infection, and vascular complications can occur; some products cannot be enzymatically reversed.
How Is the Fee Determined?Product, amount, area, technique, and review plan are determined after physician examination.Product, total amount needed, session plan, and follow-up requirements are determined after examination.

Dr. Gemici's Recommendation

A localised volume or contour goal may prompt assessment for HA filler, while broader tissue-support goals may prompt assessment for an appropriate biostimulator. Product choice should never be automatic, especially in vascularly sensitive areas such as the tear trough. Reversibility, anatomy, and the complication-management plan should be considered together.

Frequently Asked Questions

Safety and complication management

Profhilo is a safe procedure; still, as with any medical treatment, explaining possible side effects and rare complications transparently is part of patient safety. The physician-authored guides below cover these topics in depth.

This content is informational and does not replace medical advice. At any warning sign, contact the physician who performed the procedure or the nearest medical facility without delay.

Profhilo — Related Medical Terms

Deep-dive in our glossary: definition, indications, side effects and FAQs.

Sources & Regulatory Authorities

These are selected peer-reviewed medical publications. Findings are limited to the studied product, device and indication; authorization and administration route require separate verification. Publication titles are retained in their original language for reliable lookup.

A 16-week, uncontrolled study in 64 women reported improvements in skin measures. Without a comparison arm, the magnitude of benefit and superiority over alternatives remain uncertain.

Evidence summary reviewed by Dr. Hamza Gemici · · Review log

Scientific References (PubMed / Cochrane)

  1. Sparavigna A, Tenconi B. Efficacy and tolerance of an injectable medical device containing stable hybrid cooperative complexes of high- and low-molecular-weight hyaluronic acid: a monocentric 16 weeks open-label evaluation. · Clin Cosmet Investig Dermatol (2016)

    PMID 27713647DOI 10.2147/CCID.S114450

Related Services

Plan an Assessment

Contact Dr. Hamza Gemici’s clinic for individualized assessment and candidacy planning.